Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  23.13 11:10 AM EST  
    Day High 23.73 09:30 AM EST
    Range 0.60  
    Volume 511,705  
    30-Day Avg Vol 517,000
    Difference -1.02%  
    Market Cap 3.98 B  
    Mkt Cap Chg 53.91 M  
    Shares Out 168.46 M  
    % Shrs Traded 0.30%  
    1yr EPS Est 1.14  
    52-Wk Low 7.2716
    52-Wk High 27.33
    Range 20.06  
    Prev Close 23.34 2/8/10  
    Today's Open 23.73  
    Change 1.67%
    Dividend (TTM) 0.13128  
    Div Yield (TTM) 0.54%
    Ex-Div Date 07/02/2009
    Div Date 08/31/2009
    Short Interest 5.44 M

    Performance Details

    Revenue (LFY) 1.48 B  
    Earnings (LFY) -197.66 M  
    Earnings (MRQ) -48.29 M  
    Next Earn Est  
    Next Earnings 05/10/2010
    EPS (TTM) -1.22599  
    1yr EPS Growth 385.00%  
    P/E Ratio (TTM)  
    P/E Ratio (Fwd) 20.00  
    PEG Ratio 0.95  
    Return on Equity -21.87  
    Beta 1.43  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: RDY

    Blogs are not currently available for rdy.

    View all blogs at BloggingStocks.

  • Related Information: RDY

    Company Overview: RDY

    One of India's top drugmakers, Dr. Reddy's Laboratories develops and manufactures branded and unbranded generic pharmaceuticals and bulk pharmaceutical ingredients. Its stable of products includes ulcer ... View Full Description

    Earnings Analysis: RDY

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter NaN N/A
    Last Quarter 6/30/09 0.30 6/30/09
    2 Quarters Ago 3/31/09 -1.10 3/31/09

    Financials: RDY

      Quarterly - 12/31/2009 Annual - 2009
    Total Revenue 361.18 M 1.49 B
    Gross Profit 71.25 M 339.71 M
    Operating Income 53.13 M 206.79 M
    Net Income -48.29 M -197.66 M